Kymera Therapeutics

About:

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Website: http://www.kymeratx.com/

Twitter/X: kymeratx

Top Investors: BlackRock, Wellington Management, Bessemer Venture Partners, MRL Ventures Fund, Vertex Pharmaceuticals

Description:

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. It features a proprietary predictive modeling degradation platform with a novel small molecule modality to accelerate the drug discovery designed for disease-causing proteins.

Total Funding Amount:

$1.1B

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

inquiries(AT)kymeratx.com

Founders:

Nello Mainolfi

Number of Employees:

101-250

Last Funding Date:

2024-08-19

IPO Status:

Public

© 2025 bioDAO.ai